Ethyl 3-(((2-(((4-cyanophenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)pyridin-2-ylamino)propionate (CAS No: 211915-84-3) is a key pharmaceutical intermediate used in the synthesis of APIs and Dabigatran etexilate mesylate. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: Dabigatran impurity I, DeacetamidineCyanoDabigatran-d3EthylEster, 1-methyl-2-[N-(4-cyanophenyl)-aminomethyl]-benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)-amide
CAS No: 211915-84-3
PubChem CID: 11627749
Mol Formula: C27H26N6O3
Mol Weight: 482.5 g/mol
Used in APIs: and Dabigatran etexilate mesylate
IUPAC Name: ethyl 3-[[2-[(4-cyanoanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate
API Intermediate Description: Ethyl 3-(((2-(((4-cyanophenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)pyridin-2-ylamino)propionate (CAS 211915-84-3) is primarily used as a pharmaceutical intermediate and reference standard, specifically an important impurity/intermediate in the synthesis and quality control of the anticoagulant drug Dabigatran Etexilate, a direct thrombin inhibitor. Its uses are in research, drug development, and manufacturing to ensure purity and identify breakdown products of Dabigatran.
